Eugenio Marco

Eugenio Marco

Auto-generated profile, based on publicly available information

Eugenio Marco

Editas Medicine, Inc. Cambridge, MA 02141, USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2019 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MMMorgan L. Maeder
Morgan L. Maeder
MSMichael Stefanidakis
Michael Stefanidakis
CWChristopher J. Wilson
Christopher J. Wilson
RBReshica Baral
Reshica Baral
LBLuis Alberto Barrera
Luis Alberto Barrera
HJHaiyan Jiang
Haiyan Jiang

1 November 2014 in Cell
Verified
Journal Article
Closed access
ECEdmond Chipumuro
Edmond Chipumuro
EMEugenio Marco
Eugenio Marco
CCCamilla L. Christensen
Camilla L. Christensen
NKNicholas Kwiatkowski
Nicholas Kwiatkowski
TZTinghu Zhang
Tinghu Zhang
RGRani E. George
Rani E. George

24 November 2015 in Genome Biology
Verified
Journal Article
Open access
PDF file
AFAri E. Friedland
Ari E. Friedland
RBReshica Baral
Reshica Baral
PSPankhuri Singhal
Pankhuri Singhal
KLKatherine Loveluck
Katherine Loveluck
SSShen Shen
Shen Shen
DBDavid Bumcrot
David Bumcrot
CRISPR-Cas systems have been broadly embraced as effective tools for genome engineering applications, with most studies to date utilizing the Streptococcus pyogenes Cas9. Here we characterize and manipulate the smaller, 1053 amino acid nuclease Staphylococcus aureus Cas9. We find that the S. aureus Cas9 recognizes an NNGRRT protospacer adjacent motif (PAM) and cleaves target DNA at high efficiency with a variety of guide RNA (gRNA) spacer lengths. When directed against genomic targets with mutually permissive NGGRRT PAMs, the S. pyogenes Cas9 and S. aureus Cas9 yield indels at comparable rates. We additionally show D10A and N580A paired nickase activity with S. aureus Cas9, and we further package it with two gRNAs in a single functional adeno-associated virus (AAV) vector. Finally, we assess comparative S. pyogenes and S. aureus Cas9 specificity using GUIDE-seq. Our results reveal an S. aureus Cas9 that is effective for a variety of genome engineering purposes, including paired nickase approaches and all-in-one delivery of Cas9 and multiple gRNA expression cassettes with AAV vectors.

1 October 2013 in Cell Stem Cell
Verified
Journal Article
Closed access
GGGuoji Guo
Guoji Guo
SLSidinh Luc
Sidinh Luc
EMEugenio Marco
Eugenio Marco
TLTa-Wei Lin
Ta-Wei Lin
CPCong Peng
Cong Peng
SOStuart H. Orkin
Stuart H. Orkin

1 April 2007 in Cell
Verified
Journal Article
Closed access
EMEugenio Marco
Eugenio Marco
RWRoland Wedlich-Soldner
Roland Wedlich-Soldner
RLRong Li
Rong Li
SASteven J. Altschuler
Steven J. Altschuler
LWLani F. Wu
Lani F. Wu

21 March 2018 in BMC Genomics
Verified
Journal Article
Open access
PDF file
GGGeorgia Giannoukos
Georgia Giannoukos
DCDawn M. Ciulla
Dawn M. Ciulla
EMEugenio Marco
Eugenio Marco
HAHayat S. Abdulkerim
Hayat S. Abdulkerim
LBLuis A. Barrera
Luis A. Barrera
CWChristopher J. Wilson
Christopher J. Wilson
Understanding the diversity of repair outcomes after introducing a genomic cut is essential for realizing the therapeutic potential of genomic editing technologies. Targeted PCR amplification combined with Next Generation Sequencing (NGS) or enzymatic digestion, while broadly used in the genome editing field, has critical limitations for detecting and quantifying structural variants such as large deletions (greater than approximately 100 base pairs), inversions, and translocations. To overcome these limitations, we have developed a Uni-Directional Targeted Sequencing methodology, UDiTaS, that is quantitative, removes biases associated with variable-length PCR amplification, and can measure structural changes in addition to small insertion and deletion events (indels), all in a single reaction. We have applied UDiTaS to a variety of samples, including those treated with a clinically relevant pair of S. aureus Cas9 single guide RNAs (sgRNAs) targeting CEP290, and a pair of S. pyogenes Cas9 sgRNAs at T-cell relevant loci. In both cases, we have simultaneously measured small and large edits, including inversions and translocations, exemplifying UDiTaS as a valuable tool for the analysis of genome editing outcomes. UDiTaS is a robust and streamlined sequencing method useful for measuring small indels as well as structural rearrangements, like translocations, in a single reaction. UDiTaS is especially useful for pre-clinical and clinical application of gene editing to measure on- and off-target editing, large and small.